semaglutide and vision issues A new study published in the Open Access journal Pharmaceutics shows that semaglutide, also known as Ozempic, has therapeutic potential for protection against loss in people with diabetes. Diabetic retinopathy is A new study published in

Therefore, this study aimed to develop a simple and sensitive bioanalytical method using liquid chromatographytandem mass spectrometry (LCMS/MS) and determine the pharmacokinetics and brain distribution of liraglutide in rats

Semaglutide is a newer FDA approved medication for Type 2 diabetics and obese people

Leveraging genetic testing can help individuals make informed decisions to mitigate health challenges.

The future of GLP-1 therapy may become much simpler for patients

Pain Scores: Treatment resulted in a 75.8% reduction in WOMAC pain scores compared to baseline

Our capabilities include: High-protein nutritional formulations Muscle preservation and recovery solutions Gastrointestinal support formulations Micronutrient replenishment systems Specialized clinical nutrition products Custom product development for healthcare brands and institutions As GLP-1 therapies continue to evolve, personalized nutrition will become an essential component of patient success